ALFA Finder| Revenue growth | 6.6% YoY for FY26 Consolidated. |
|---|---|
| Margins | EBITDA margins improved to 13.8% in FY26. |
| Order book | High-value orders deferred to subsequent quarters. |
| Demand visibility | Strong institutional relationships with pharma and academia. |
| Management confidence | High, targeting medium-term CAGR of 12-14%. |
Growth
FY26 Consolidated Revenue reached ₹467.3cr (6.6% growth); PAT grew 29.4% to ₹34.6cr.
Outlook
Medium-term Revenue CAGR target of 12-14% with focused margin improvement via high-value segments.
Risks
Impacted by one-time Ambad plant closure costs and sales reversal in Process Systems.
Earnings Call filed with NSE, NSE: BOROSCI. Summary written with AI assistance from the document.
Borosil Scientific Ltd: key numbers
- Share price
- ₹112.77
- Market cap
- ₹1,003 Cr
- Revenue (annual)
- ₹467.3 Cr
- Net profit (annual)
- ₹34.61 Cr
- P/E (TTM)
- 22.0×Sector 46.8×
- Promoter holding
- 68.27%+0.00% QoQ
- FII holding
- 0.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Borosil Scientific Ltd
All →Borosil Scientific Investor Presentation: Key Takeaways
Q2FY27 consolidated sales ₹115.0 Cr (+7.6%), EBITDA ₹11.0 Cr (+29.4%), PAT ₹5.3 Cr (+86.3%). Standalone PAT fell 16.9% on input costs.
Borosil Scientific Capacity Expansion: ₹70 Cr Investment
Borosil Scientific approved a Rs.70 Crore, 20 MT per day glass tubing furnace. Commercial production is expected by March 2028.
- Value
- ₹70.00 Cr
- Execution
- Commercial production expected by March 31, 2028
- borosilicate glass tubing production capacity
- 20.0 MT per day
Borosil Scientific Q2 FY27 Results: Net Profit ₹5.3 Cr, Up 89.3% YoY
Borosil Scientific Ltd reported revenue from operations of ₹115 Cr (+7.6% YoY) and net profit of ₹5.3 Cr (+89.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹5.3 Cr · +89.3% YoY
Borosil Scientific Board Meeting Date
Borosil Scientific Limited will hold a board meeting on October 28, 2026, to consider and approve its unaudited financial results for the quarter ended September 30, 2026.
Borosil Scientific Other Announcement
Borosil Scientific Ltd submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026. This is a routine periodic regulatory disclosure.
Borosil Scientific Other Announcement
Borosil Scientific Limited filed the quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, as issued by its Registrar and Transfer Agent.